Speaker(s): 

Sheng-Ying Margaret Lo, PhD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Alfred Kennedy, MD, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1) describe the advantages and limitations of drug detection methods used in acute care.
2) identify best practices for managing unexpected urine drug screen results.
3) recognize tools and approaches laboratory professionals use to assist clinicians in interpreting toxicology findings.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Kelly B. Smith, BSN, RN, CPN; Alfred Kennedy Jr., MD and Bryan Walters, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None